(2R,3S)-(+)- and (2S,3R)-(−)-Halofuginone lactate: Synthesis, absolute configuration, and activity against Cryptosporidium parvum
- 21 May 2007
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (15), 4140-4143
- https://doi.org/10.1016/j.bmcl.2007.05.053
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Development and validation of a cell culture based assay for in vitro assessment of anticryptosporidial compoundsZeitschrift für Parasitenkunde, 2007
- Drug therapies for uterine fibroids: a new approach to an old problemDrug Discovery Today: Therapeutic Strategies, 2004
- Putting chirality to work: the strategy of chiral switchesNature Reviews Drug Discovery, 2002
- Halofuginone: From veterinary use to human therapyDrug Development Research, 2000
- Catalytic Asymmetric Synthesis of Antimalarial Alkaloids Febrifugine and Isofebrifugine and Their Biological ActivityThe Journal of Organic Chemistry, 1999
- Chemotherapy and delivery systems: haemoparasitesVeterinary Parasitology, 1994
- Chirale Lactole, II. Racematspaltung und enantioselektive Acetalisierung mit der 2,3,3a,4,5,6,7,7a‐Octahydro‐7,8,8‐trimethyl‐4,7‐methanobenzofuran‐2‐yl‐SchutzgruppeEuropean Journal of Inorganic Chemistry, 1982